Long-Acting Drug Delivery Technologies and Services Market, By Material (Polymer-based and Non-polymer Based), By Dosage Form, By End User, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-203
REPORT HIGHLIGHT
Long-Acting Drug Delivery Technologies and Services Market size was valued at USD 12,234.23 Million in 2023, expanding at a CAGR of 11.2% from 2024 to 2032.
Long-Acting Drug Delivery Technologies and Services imply advanced methods and systems designed to administer medications over extended periods with fewer doses compared to traditional methods. These technologies aim to improve patient adherence, enhance therapeutic efficacy, and reduce the frequency of administration.
Long-Acting Drug Delivery Technologies and Services Market- Market Dynamics
Increasing patient adherence and the prevalence of hypertension, and psychiatric diseases are expected to propel market demand
Diabetes, hypertension, cancer, and psychiatric disorders are increasingly common and often require long-term management. Long-acting formulations reduce the frequency of dosing and improve patient adherence which is expected to bolster market growth. There is a growing emphasis on preventive healthcare, which includes using long-acting medications to manage conditions before they become severe, thereby improving quality of life and reducing long-term healthcare costs.
The development of long-acting formulations for biologics and biosimilars is expanding the market. These drugs often require complex delivery systems to maintain stability and effectiveness over time. Innovations in pharmaceutical technology, such as nano-based drug delivery systems, advanced polymers, and improved formulation techniques, are making long-acting drug delivery systems more effective and versatile. Enhanced convenience from fewer doses and less frequent administration encourages patients to stick to their treatment plans, which can lead to better health outcomes and reduced healthcare costs. All these benefits are projected to contribute to market growth.
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL LONG-ACTING DRUG DELIVERY TECHNOLOGIES AND SERVICES MARKET KEY PLAYERS
Pfizer Inc.
Roche Holding AG
Novartis International AG
Johnson & Johnson
Boehringer Ingelheim
Bristol-Myers Squibb
Viatris Inc.
ALZA Corporation
Eli Lilly and Company
Merck & Co., Inc.
Sanofi S.A.
AbbVie Inc.
Gilead Sciences, Inc.
GlaxoSmithKline plc
AstraZeneca plc
Others
GLOBAL LONG-ACTING DRUG DELIVERY TECHNOLOGIES AND SERVICES MARKET, BY MATERIAL- MARKET ANALYSIS, 2019-2032
Polymer-based
Non-polymer Based
GLOBAL LONG-ACTING DRUG DELIVERY TECHNOLOGIES AND SERVICES MARKET, BY DOSAGE FORM- MARKET ANALYSIS, 2019-2032
Long Acting Injectables
Long Acting Implantable
Long-acting Oral
Others
GLOBAL LONG-ACTING DRUG DELIVERY TECHNOLOGIES AND SERVICES MARKET, BY END USER- MARKET ANALYSIS, 2019-2032
Pharmaceutical & Biotech Companies
Research & Development
Others
GLOBAL LONG-ACTING DRUG DELIVERY TECHNOLOGIES AND SERVICES MARKET, BY REGION- MARKET ANALYSIS, 2019-2032
North America
o The U.S.
o Canada
Europe
o Germany
o France
o Italy
o Spain
o United Kingdom
o Russia
o Netherlands
o Sweden
o Poland
o Rest of Europe
Asia Pacific
o India
o China
o South Korea
o Japan
o Australia
o Thailand
o Indonesia
o Philippines
o Rest of APAC
Latin America
o Brazil
o Mexico
o Argentina
o Colombia
o Rest of LATAM
The Middle East and Africa
o Saudi Arabia
o United Arab Emirates
o Israel
o Turkey
o Algeria
o Egypt
o Rest of MEA
TABLE OF CONTENT
1. Long-Acting Drug Delivery Technologies and Services Market Overview
1.1. Study Scope
1.2. Market Estimation Years
2. Executive Summary
2.1. Market Snippet
2.1.1. Long-Acting Drug Delivery Technologies and Services Market Snippet by Material
2.1.2. Long-Acting Drug Delivery Technologies and Services Market Snippet by Dosage Form
2.1.3. Long-Acting Drug Delivery Technologies and Services Market Snippet by End User
2.1.4. Long-Acting Drug Delivery Technologies and Services Market Snippet by Country
2.1.5. Long-Acting Drug Delivery Technologies and Services Market Snippet by Region
2.2. Competitive Insights
3. Long-Acting Drug Delivery Technologies and Services Key Market Trends
3.1. Long-Acting Drug Delivery Technologies and Services Market Drivers
3.1.1. Impact Analysis of Market Drivers
3.2. Long-Acting Drug Delivery Technologies and Services Market Restraints
3.2.1. Impact Analysis of Market Restraints
3.3. Long-Acting Drug Delivery Technologies and Services Market Opportunities
3.4. Long-Acting Drug Delivery Technologies and Services Market Future Trends
4. Long-Acting Drug Delivery Technologies and Services Industry Study
4.1. PEST Analysis
4.2. Porter’s Five Forces Analysis
4.3. Growth Prospect Mapping
4.4. Regulatory Framework Analysis
5. Long-Acting Drug Delivery Technologies and Services Market: COVID-19 Impact Analysis
5.1. Pre-COVID-19 Impact Analysis
5.2. Post-COVID-19 Impact Analysis
5.2.1. Top Performing Segments
5.2.2. Marginal Growth Segments
5.2.3. Top Looser Segments
5.2.4. Marginal Loss Segments
6. Long-Acting Drug Delivery Technologies and Services Market Landscape
6.1. Long-Acting Drug Delivery Technologies and Services Market Share Analysis, 2023
6.2. Breakdown Data, by Key Manufacturer
6.2.1. Established Players’ Analysis
6.2.2. Emerging Players’ Analysis
7. Long-Acting Drug Delivery Technologies and Services Market – By Material
7.1. Overview
7.1.1. Segment Share Analysis, By Material, 2024 & 2032 (%)
7.1.2. Polymer-based
7.1.3. Non-polymer Based
8. Long-Acting Drug Delivery Technologies and Services Market – By Dosage Form
8.1. Overview
8.1.1. Segment Share Analysis, By Dosage Form, 2024 & 2032 (%)
8.1.2. Long Acting Injectables
8.1.3. Long Acting Implantable
8.1.4. Long-acting Oral
8.1.5. Others
9. Long-Acting Drug Delivery Technologies and Services Market – By End User
9.1. Overview
9.1.1. Segment Share Analysis, By End User, 2024 & 2032 (%)
9.1.2. Pharmaceutical & Biotech Companies
9.1.3. Research & Development
9.1.4. Others
10. Long-Acting Drug Delivery Technologies and Services Market– By Geography
10.1. Introduction
10.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
10.2. North America
10.2.1. Overview
10.2.2. Long-Acting Drug Delivery Technologies and Services Key Manufacturers in North America
10.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
10.2.4. North America Market Size and Forecast, By Material, 2019 - 2032 (US$ Million)
10.2.5. North America Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
10.2.6. North America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.2.7. U.S.
10.2.7.1. Overview
10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.2.7.3. U.S. Market Size and Forecast, By Material, 2019 - 2032 (US$ Million)
10.2.7.4. U.S. Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
10.2.7.5. U.S. Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.2.8. Canada
10.2.8.1. Overview
10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.2.8.3. Canada Market Size and Forecast, By Material, 2019 - 2032 (US$ Million)
10.2.8.4. Canada Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
10.2.8.5. Canada Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.3. Europe
10.3.1. Overview
10.3.2. Long-Acting Drug Delivery Technologies and Services Key Manufacturers in Europe
10.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
10.3.4. Europe Market Size and Forecast, By Material, 2019 - 2032 (US$ Million)
10.3.5. Europe Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
10.3.6. Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.3.7. Germany
10.3.7.1. Overview
10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.7.3. Germany Market Size and Forecast, By Material, 2019 - 2032 (US$ Million)
10.3.7.4. Germany Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
10.3.7.5. Germany Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.3.8. Italy
10.3.8.1. Overview
10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.8.3. Italy Market Size and Forecast, By Material, 2019 - 2032 (US$ Million)
10.3.8.4. Italy Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
10.3.8.5. Italy Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.3.9. United Kingdom
10.3.9.1. Overview
10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.9.3. United Kingdom Market Size and Forecast, By Material, 2019 - 2032 (US$ Million)
10.3.9.4. United Kingdom Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
10.3.9.5. United Kingdom Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.3.10. France
10.3.10.1. Overview
10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.10.3. France Market Size and Forecast, By Material, 2019 - 2032 (US$ Million)
10.3.10.4. France Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
10.3.10.5. France Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.3.11. Russia
10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.11.2. Russia Market Size and Forecast, By Material, 2019 - 2032 (US$ Million)
10.3.11.3. Russia Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
10.3.11.4. Russia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.3.12. Netherlands
10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.12.2. Netherlands Market Size and Forecast, By Material, 2019 - 2032 (US$ Million)
10.3.12.3. Netherlands Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
10.3.12.4. Netherlands Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.3.13. Sweden
10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.13.2. Sweden Market Size and Forecast, By Material, 2019 - 2032 (US$ Million)
10.3.13.3. Sweden Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
10.3.13.4. Sweden Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.3.14. Poland
10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.14.2. Poland Market Size and Forecast, By Material, 2019 - 2032 (US$ Million)
10.3.14.3. Poland Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
10.3.14.4. Poland Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.3.15. Rest of Europe
10.3.15.1. Overview
10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.15.3. Rest of the Europe Market Size and Forecast, By Material, 2019 - 2032 (US$ Million)
10.3.15.4. Rest of the Europe Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
10.3.15.5. Rest of the Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.4. Asia Pacific (APAC)
10.4.1. Overview
10.4.2. Long-Acting Drug Delivery Technologies and Services Key Manufacturers in Asia Pacific
10.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
10.4.4. Asia Pacific Market Size and Forecast, By Material, 2019 - 2032 (US$ Million)
10.4.5. Asia Pacific Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
10.4.6. Asia Pacific Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.4.7. India
10.4.7.1. Overview
10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.4.7.3. India Market Size and Forecast, By Material, 2019 - 2032 (US$ Million)
10.4.7.4. India Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
10.4.7.5. India Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.4.8. China
10.4.8.1. Overview
10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.4.8.3. China Market Size and Forecast, By Material, 2019 - 2032 (US$ Million)
10.4.8.4. China Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
10.4.8.5. China Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.4.9. Japan
10.4.9.1. Overview
10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.4.9.3. Japan Market Size and Forecast, By Material, 2019 - 2032 (US$ Million)
10.4.9.4. Japan Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
10.4.9.5. Japan Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.4.10. South Korea
10.4.10.1. Overview
10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.4.10.3. South Korea Market Size and Forecast, By Material, 2019 - 2032 (US$ Million)
10.4.10.4. South Korea Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
10.4.10.5. South Korea Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.4.11. Australia
10.4.11.1. Overview
10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.4.11.3. Australia Market Size and Forecast, By Material, 2019 - 2032 (US$ Million)
10.4.11.4. Australia Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
10.4.11.5. Australia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.4.12. Thailand
10.4.12.1. Overview
10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.4.12.3. Thailand Market Size and Forecast, By Material, 2019 - 2032 (US$ Million)
10.4.12.4. Thailand Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
10.4.12.5. Thailand Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.4.13. Indonesia
10.4.13.1. Overview
10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.4.13.3. Indonesia Market Size and Forecast, By Material, 2019 - 2032 (US$ Million)
10.4.13.4. Indonesia Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
10.4.13.5. Indonesia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.4.14. Philippines
10.4.14.1. Overview
10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.4.14.3. Philippines Market Size and Forecast, By Material, 2019 - 2032 (US$ Million)
10.4.14.4. Philippines Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
10.4.14.5. Philippines Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.4.15. Rest of APAC
10.4.15.1. Overview
10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.4.15.3. Rest of APAC Market Size and Forecast, By Material, 2019 - 2032 (US$ Million)
10.4.15.4. Rest of APAC Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
10.4.15.5. Rest of APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.5. Latin America
10.5.1. Overview
10.5.2. Long-Acting Drug Delivery Technologies and Services Key Manufacturers in Latin America
10.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
10.5.4. Latin America Market Size and Forecast, By Material, 2019 - 2032 (US$ Million)
10.5.5. Latin America Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
10.5.6. Latin America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.5.7. Brazil
10.5.7.1. Overview
10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.5.7.3. Brazil Market Size and Forecast, By Material, 2019 - 2032 (US$ Million)
10.5.7.4. Brazil Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
10.5.7.5. Brazil Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.5.8. Mexico
10.5.8.1. Overview
10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.5.8.3. Mexico Market Size and Forecast, By Material, 2019 - 2032 (US$ Million)
10.5.8.4. Mexico Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
10.5.8.5. Mexico Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.5.9. Argentina
10.5.9.1. Overview
10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.5.9.3. Argentina Market Size and Forecast, By Material, 2019 - 2032 (US$ Million)
10.5.9.4. Argentina Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
10.5.9.5. Argentina Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.5.10. Colombia
10.5.10.1. Overview
10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.5.10.3. Colombia Market Size and Forecast, By Material, 2019 - 2032 (US$ Million)
10.5.10.4. Colombia Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
10.5.10.5. Colombia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.5.11. Rest of LATAM
10.5.11.1. Overview
10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.5.11.3. Rest of LATAM Market Size and Forecast, By Material, 2019 - 2032 (US$ Million)
10.5.11.4. Rest of LATAM Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
10.5.11.5. Rest of LATAM Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.6. Middle East and Africa
10.6.1. Overview
10.6.2. Long-Acting Drug Delivery Technologies and Services Key Manufacturers in Middle East and Africa
10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
10.6.4. Middle East and Africa Market Size and Forecast, By Material, 2019 - 2032 (US$ Million)
10.6.5. Middle East and Africa Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
10.6.6. Middle East and Africa Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.6.7. Saudi Arabia
10.6.7.1. Overview
10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.6.7.3. Saudi Arabia Market Size and Forecast, By Material, 2019 - 2032 (US$ Million)
10.6.7.4. Saudi Arabia Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
10.6.7.5. Saudi Arabia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.6.8. United Arab Emirates
10.6.8.1. Overview
10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.6.8.3. United Arab Emirates Market Size and Forecast, By Material, 2019 - 2032 (US$ Million)
10.6.8.4. United Arab Emirates Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
10.6.8.5. United Arab Emirates Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.6.9. Israel
10.6.9.1. Overview
10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.6.9.3. Israel Market Size and Forecast, By Material, 2019 - 2032 (US$ Million)
10.6.9.4. Israel Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
10.6.9.5. Israel Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.6.10. Turkey
10.6.10.1. Overview
10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.6.10.3. Turkey Market Size and Forecast, By Material, 2019 - 2032 (US$ Million)
10.6.10.4. Turkey Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
10.6.10.5. Turkey Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.6.11. Algeria
10.6.11.1. Overview
10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.6.11.3. Algeria Market Size and Forecast, By Material, 2019 - 2032 (US$ Million)
10.6.11.4. Algeria Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
10.6.11.5. Algeria Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.6.12. Egypt
10.6.12.1. Overview
10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.6.12.3. Egypt Market Size and Forecast, By Material, 2019 - 2032 (US$ Million)
10.6.12.4. Egypt Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
10.6.12.5. Egypt Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.6.13. Rest of MEA
10.6.13.1. Overview
10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.6.13.3. Rest of MEA Market Size and Forecast, By Material, 2019 - 2032 (US$ Million)
10.6.13.4. Rest of MEA Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
10.6.13.5. Rest of MEA Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11. Key Vendor Analysis- Long-Acting Drug Delivery Technologies and Services Industry
11.1. Competitive Dashboard
11.2. Company Profiles
11.2.1. Pfizer Inc.
11.2.2. Roche Holding AG
11.2.3. Novartis International AG
11.2.4. Johnson & Johnson
11.2.5. Boehringer Ingelheim
11.2.6. Bristol-Myers Squibb
11.2.7. Viatris Inc.
11.2.8. ALZA Corporation
11.2.9. Eli Lilly and Company
11.2.10. Merck & Co., Inc.
11.2.11. Sanofi S.A.
11.2.12. AbbVie Inc.
11.2.13. Gilead Sciences, Inc.
11.2.14. GlaxoSmithKline plc
11.2.15. AstraZeneca plc
11.2.16. Others
12. 360 Degree Analyst View
13. Appendix
13.1. Research Methodology
13.2. References
13.3. Abbreviations
13.4. Disclaimer
13.5. Contact Us
